Zaid Abassi

7.8k total citations
205 papers, 5.8k citations indexed

About

Zaid Abassi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Zaid Abassi has authored 205 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cardiology and Cardiovascular Medicine, 47 papers in Molecular Biology and 46 papers in Nephrology. Recurrent topics in Zaid Abassi's work include Nitric Oxide and Endothelin Effects (38 papers), Heart Failure Treatment and Management (33 papers) and Acute Kidney Injury Research (29 papers). Zaid Abassi is often cited by papers focused on Nitric Oxide and Endothelin Effects (38 papers), Heart Failure Treatment and Management (33 papers) and Acute Kidney Injury Research (29 papers). Zaid Abassi collaborates with scholars based in Israel, United States and Germany. Zaid Abassi's co-authors include Joseph Winaver, Aaron Hoffman, Samuel N. Heyman, Farid Nakhoul, Ori S. Better, Tony Karram, Harry R. Keiser, Zaher Armaly, Mordechai Yigla and Shimon A. Reisner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Zaid Abassi

199 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zaid Abassi Israel 42 2.1k 1.2k 1.2k 947 938 205 5.8k
Bernhard K. Krämer Germany 42 1.6k 0.8× 806 0.7× 1.7k 1.4× 1.7k 1.7× 1.2k 1.3× 355 7.8k
Magnus Bäck Sweden 49 2.1k 1.0× 1.2k 1.0× 2.1k 1.7× 1.6k 1.7× 1.3k 1.4× 190 8.5k
Bernhard F. Becker Germany 51 1.6k 0.8× 914 0.7× 1.3k 1.1× 1.9k 2.0× 1.0k 1.1× 123 8.7k
Martin Tepel Germany 45 1.5k 0.7× 1.0k 0.8× 2.0k 1.6× 1.3k 1.4× 1.3k 1.4× 266 8.6k
Bernhard M. W. Schmidt Germany 36 1.3k 0.6× 496 0.4× 728 0.6× 989 1.0× 683 0.7× 114 4.5k
Lars Christian Rump Germany 46 3.1k 1.5× 1.1k 0.9× 1.1k 0.9× 1.7k 1.8× 868 0.9× 199 7.5k
Jan‐Luuk Hillebrands Netherlands 39 603 0.3× 640 0.5× 1.5k 1.2× 1.2k 1.3× 535 0.6× 173 6.1k
Aldo Clerico Italy 45 4.3k 2.1× 852 0.7× 1.0k 0.9× 979 1.0× 507 0.5× 261 6.9k
Duska Dragun Germany 51 1.3k 0.6× 754 0.6× 1.5k 1.2× 2.5k 2.7× 680 0.7× 167 8.7k
Steven D. Crowley United States 42 1.9k 0.9× 553 0.4× 2.1k 1.7× 476 0.5× 478 0.5× 109 6.0k

Countries citing papers authored by Zaid Abassi

Since Specialization
Citations

This map shows the geographic impact of Zaid Abassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaid Abassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaid Abassi more than expected).

Fields of papers citing papers by Zaid Abassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zaid Abassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaid Abassi. The network helps show where Zaid Abassi may publish in the future.

Co-authorship network of co-authors of Zaid Abassi

This figure shows the co-authorship network connecting the top 25 collaborators of Zaid Abassi. A scholar is included among the top collaborators of Zaid Abassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zaid Abassi. Zaid Abassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamoud, Shadi, et al.. (2024). Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury. International Journal of Molecular Sciences. 25(6). 3544–3544. 3 indexed citations
3.
Abassi, Zaid, et al.. (2024). The endocrine basis of the cardio‐renal axis: New perspectives regarding corin. Physiological Reports. 12(13). e16105–e16105. 3 indexed citations
4.
Heyman, S, Doron Aronson, & Zaid Abassi. (2024). SGLT2 Inhibitors and the Risk of Contrast-Associated Nephropathy Following Angiographic Intervention: Contradictory Concepts and Clinical Outcomes. International Journal of Molecular Sciences. 25(19). 10759–10759. 3 indexed citations
5.
Sabo, Edmond, et al.. (2024). Involvement of heparanase in the pathogenesis of acute pancreatitis: Implication of novel therapeutic approaches. Journal of Cellular and Molecular Medicine. 28(17). e18512–e18512. 1 indexed citations
6.
Heyman, Samuel N. & Zaid Abassi. (2023). Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven?. Journal of Clinical Medicine. 12(14). 4871–4871. 5 indexed citations
9.
Nativ, Omri, Safa Kinaneh, Doron Aronson, et al.. (2023). Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure. International Journal of Molecular Sciences. 24(14). 11470–11470. 5 indexed citations
10.
Gamliel-Lazarovich, Aviva, Yaniv Zohar, Neta Ilan, et al.. (2022). Heparanase Increases Podocyte Survival and Autophagic Flux after Adriamycin-Induced Injury. International Journal of Molecular Sciences. 23(20). 12691–12691. 2 indexed citations
11.
Heyman, Samuel N., Itamar Raz, & Zaid Abassi. (2022). Letter Regarding Normal Albuminuria in Patients With Autopsy-Proven Advanced Diabetic Nephropathy. Kidney International Reports. 7(3). 662–662. 1 indexed citations
12.
Younis, Johnny S., Karl Skorecki, & Zaid Abassi. (2021). The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic. Frontiers in Endocrinology. 12. 607179–607179. 22 indexed citations
13.
Kinaneh, Safa, et al.. (2021). Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID‐19 disease. Journal of Cellular and Molecular Medicine. 25(8). 3840–3855. 19 indexed citations
14.
Kinaneh, Safa, et al.. (2021). Identification, localization and expression of NHE isoforms in the alveolar epithelial cells. PLoS ONE. 16(4). e0239240–e0239240. 7 indexed citations
15.
Abu‐Saleh, Niroz, et al.. (2020). Combination of hyperglycaemia and hyperlipidaemia induces endothelial dysfunction: Role of the endothelin and nitric oxide systems. Journal of Cellular and Molecular Medicine. 25(4). 1884–1895. 14 indexed citations
16.
Aronson, Doron, et al.. (2019). Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure. Journal of Cellular and Molecular Medicine. 23(7). 4779–4794. 6 indexed citations
17.
Aronson, Doron, et al.. (2013). Fluid Loss, Venous Congestion, and Worsening Renal Function in Acute Decompensated Heart Failure. European Journal of Heart Failure. 15(6). 637–643. 60 indexed citations
18.
Guetta, Julia, Gidon Berger, Bishara Bishara, et al.. (2012). Vasopressin-2 Receptor Antagonist Attenuates the Ability of the Lungs to Clear Edema in an Experimental Model. American Journal of Respiratory Cell and Molecular Biology. 47(5). 583–588. 5 indexed citations
19.
Abu‐Saleh, Niroz, Hoda Awad, Mogher Khamaisi, et al.. (2012). Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model. Life Sciences. 91(13-14). 669–675. 23 indexed citations
20.
Abassi, Zaid, Zaher Armaly, Farid Nakhoul, & Aaron Hoffman. (2008). [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].. PubMed. 147(6). 536–42, 573. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026